Journal article
HelR is a helicase-like protein that protects RNA polymerase from rifamycin antibiotics
Abstract
Rifamycin antibiotics such as rifampin are potent inhibitors of prokaryotic RNA polymerase (RNAP) used to treat tuberculosis and other bacterial infections. Although resistance arises in the clinic principally through mutations in RNAP, many bacteria possess highly specific enzyme-mediated resistance mechanisms that modify and inactivate rifamycins. The expression of these enzymes is controlled by a 19-bp cis-acting rifamycin-associated element …
Authors
Surette MD; Waglechner N; Koteva K; Wright GD
Journal
Molecular Cell, Vol. 82, No. 17, pp. 3151–3165.e9
Publisher
Elsevier
Publication Date
September 2022
DOI
10.1016/j.molcel.2022.06.019
ISSN
1097-2765